X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
dyskinesia (19) 19
neurosciences (18) 18
animals (17) 17
index medicus (17) 17
rats (16) 16
l-dopa (14) 14
parkinson's disease (14) 14
rats, sprague-dawley (14) 14
serotonin (14) 14
dopamine (13) 13
disease models, animal (10) 10
male (10) 10
female (9) 9
medical and health sciences (9) 9
medicin och hälsovetenskap (9) 9
movement disorders (9) 9
neurology (8) 8
dyskinesia, drug-induced - drug therapy (7) 7
parkinsons-disease (7) 7
phenols (7) 7
basic medicine (6) 6
clinical neurology (6) 6
levodopa - adverse effects (6) 6
levodopa-induced dyskinesia (6) 6
medicinska och farmaceutiska grundvetenskaper (6) 6
motor activity - drug effects (6) 6
neurons (6) 6
neurovetenskaper (6) 6
oxidopamine - toxicity (6) 6
parkinson disease - drug therapy (6) 6
striatum (6) 6
6-ohda (5) 5
behavior, animal - drug effects (5) 5
humans (5) 5
levodopa - toxicity (5) 5
models (5) 5
[ sdv ] life sciences [q-bio] (4) 4
abnormal involuntary movements (4) 4
amphetamine (4) 4
analysis (4) 4
antiparkinson agents - adverse effects (4) 4
antiparkinson agents - pharmacology (4) 4
apomorphine (4) 4
dopa-induced dyskinesia (4) 4
dose-response relationship, drug (4) 4
dyskinesia, drug-induced - metabolism (4) 4
dyskinesia, drug-induced - physiopathology (4) 4
expression (4) 4
levodopa - pharmacology (4) 4
life sciences (4) 4
mechanisms (4) 4
oxidopamine (4) 4
parkinsonian disorders - drug therapy (4) 4
substantia-nigra (4) 4
tremor (4) 4
triazoles - pharmacology (4) 4
5-ht1a receptor stimulation (3) 3
amantadine (3) 3
antiparkinson agents - toxicity (3) 3
behavior (3) 3
clinical medicine (3) 3
corpus striatum - drug effects (3) 3
corpus striatum - metabolism (3) 3
gaba (3) 3
glutamate (3) 3
glutamate decarboxylase - genetics (3) 3
health aspects (3) 3
klinisk medicin (3) 3
levodopa (3) 3
macaca fascicularis (3) 3
neurologi (3) 3
neurology. diseases of the nervous system (3) 3
neuroprotection (3) 3
parkinson disease - etiology (3) 3
parkinsonian disorders - chemically induced (3) 3
parkinson’s disease (3) 3
pyrimidines - pharmacology (3) 3
rat model (3) 3
receptor agonists (3) 3
review article (3) 3
rna, messenger - metabolism (3) 3
sarizotan (3) 3
time factors (3) 3
5-alpha-reductase (2) 2
5-ht1 receptor (2) 2
5-ht1a (2) 2
activation (2) 2
adenine - analogs & derivatives (2) 2
adenine - pharmacology (2) 2
adenosine a2 receptor antagonists (2) 2
adrenergic agents - toxicity (2) 2
aims (2) 2
akinesia (2) 2
amantadine - therapeutic use (2) 2
amphetamine - toxicity (2) 2
animal models (2) 2
antiparkinsonian agents (2) 2
article subject (2) 2
behavioral recovery (2) 2
brain (2) 2
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Frontiers in Neurology, ISSN 1664-2295, 2014, Volume 5
In the recent years, the serotonin system has emerged as a key player in the induction of L-DOPA-induced dyskinesia (LID) in animal models of Parkinson's... 
5-HT1 receptor | Dopamine | Parkinson's disease | Serotonin | L-DOPA | Dyskinesia | SARIZOTAN | LEVODOPA-INDUCED DYSKINESIAS | RECEPTOR AGONISTS | MECHANISMS | dyskinesia | SUBSTANTIA-NIGRA | NEUROSCIENCES | RAT MODEL | CLINICAL NEUROLOGY | serotonin | 5-HT1A | dopamine | EXPRESSION | MOTOR COMPLICATIONS | PARKINSONS-DISEASE | L-Dopa | Parkinson’s disease
Journal Article
Journal of neural transmission (Vienna, Austria : 1996), 12/2017
Appearance of L-DOPA-induced dyskinesia (LID) represents a major limitation in the pharmacological therapy with the dopamine precursor L-DOPA. Indeed, the vast... 
Journal Article
Movement Disorders, ISSN 0885-3185, 07/2013, Volume 28, Issue 8, pp. 1088 - 1096
Journal Article
Frontiers in neurology, ISSN 1664-2295, 2014, Volume 5, p. 78
In the recent years, the serotonin system has emerged as a key player in the induction of l-DOPA-induced dyskinesia (LID) in animal models of Parkinson's... 
Journal Article
Movement Disorders, ISSN 0885-3185, 04/2016, Volume 31, Issue 4, pp. 501 - 511
Journal Article
Journal Article
Basal Ganglia, ISSN 2210-5336, 03/2013, Volume 3, Issue 1, pp. 9 - 13
Appearance of dyskinesia represents the most problematic side effect during chronic L-DOPA treatment in parkinsonian patients, with serious consequences for... 
6-OHDA | Dopamine | Serotonin | 5HT1 receptor agonists | L-DOPA | Dyskinesia
Journal Article
Journal Article
Progress in Neurobiology, ISSN 0301-0082, 09/2015, Volume 132, Issue Jul 21, pp. 96 - 168
Journal Article